Cancer Health Treatment Update CAR-T Therapy Highly Effective for People with High-Risk Non-Hodgkin Lymphoma Yescarta led to complete remission in nearly 80% of people with advanced non-Hodgkin lymphoma. Three Countries Authorize Pfizer COVID-19 Vaccine Newly released data look good, and the U.S. could do the same after a public hearing today. Circulating Tumor Cells May Predict Prognosis in Patients with Metastatic Breast Cancer A simple blood test can reveal treatment response faster than conventional imaging scans. Most Women Who Have Survived Breast Cancer Deliver Healthy Babies Survivors have a harder time conceiving, but the odds are their babies will be healthy. Opdivo-Yervoy Combo Modestly Effective Against Advanced Prostate Cancer Historically, prostate cancer has been resistant to checkpoint inhibitor immunotherapy. Cancer Survivors at Greater Risk of Flu Complications Those with blood cancers are nine times more likely to be hospitalized or die from the flu. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Fall 2020 Check out our latest print edition! Advertisement Newsfeed Three Countries Authorize Pfizer COVID-19 Vaccine “Faces of Hope”: Biden Names Infectious Disease Expert to Lead CDC Demand for COVID Vaccines Expected to Get Heated—And Fast Former Presidents Plan to Publicly Get the COVID-19 Vaccine Blog: Food and Drug Administration (FDA) FDA Approves Gavreto for RET-Altered Thyroid Cancers FDA Approves High Intensity Focused Ultrasound for Bone Tumors FDA Grants Accelerated Approval of Danyelza For Neuroblastoma in the Bones FDA Approves Liquid Biopsy Test For Multiple Cancers and Biomarkers Newsfeed Three Countries Authorize Pfizer COVID-19 Vaccine “Faces of Hope”: Biden Names Infectious Disease Expert to Lead CDC Demand for COVID Vaccines Expected to Get Heated—And Fast Former Presidents Plan to Publicly Get the COVID-19 Vaccine Blog: Food and Drug Administration (FDA) FDA Approves Gavreto for RET-Altered Thyroid Cancers FDA Approves High Intensity Focused Ultrasound for Bone Tumors FDA Grants Accelerated Approval of Danyelza For Neuroblastoma in the Bones FDA Approves Liquid Biopsy Test For Multiple Cancers and Biomarkers

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: